Scholarly Index
Andrew M. Brunner
Massachusetts General Hospital; 5,537 total citations; 294 total publications; best world rank #76
Massachusetts General Hospital
5,537Total citations
294Total publications
39H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Acute Myeloid Leukemia Research | Lifetime | 837 | US 375 | 97.79 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 611 | US 256 | 95.85 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 938 | US 391 | 96.23 |
| Histone Deacetylase Inhibitors Research | Lifetime | 910 | US 405 | 93.05 |
| Acute Myeloid Leukemia Research | 2021-2025 | 80 | US 51 | 99.10 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 76 | US 35 | 94.70 |
| Acute Lymphoblastic Leukemia research | 2021-2025 | 216 | US 123 | 96.44 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 132 | US 78 | 96.63 |
| Neutropenia and Cancer Infections | 2021-2025 | 76 | US 31 | 93.91 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 239 | US 120 | 95.65 |
| Hematopoietic Stem Cell Transplantation | 2021-2025 | 458 | US 202 | 92.73 |
| Hematological disorders and diagnostics | 2021-2025 | 482 | US 128 | 63.95 |
| Blood disorders and treatments | 2021-2025 | 874 | US 204 | 60.61 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 805 | US 236 | 53.67 |